Gilla Kaplan - 31 Mar 2022 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Jennifer Zoltoski, by Power of Attorney
Issuer symbol
AVTX
Transactions as of
31 Mar 2022
Transactions value $
$0
Form type
4
Date filed
04 Apr 2022, 17:37
Previous filing
04 Jan 2022
Next filing
15 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +30.4K $0.00 30.4K 31 Mar 2022 Common Stock 30.4K $0.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the stock option will immediately vest on the date that it is granted.